With a steady 𝟏𝟎% 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞, the pharmaceutical sector continues to showcase resilience, innovation, and its vital role in

PPMA North Chairman Saad Javed Akram met Mr. Tahir Habib Cheema (Collector of Customs) for a constructive discussion on industry

DRAP & SECP sign MoU for eService Portal integration. Signed by Dr. Obaidullah (CEO, DRAP) & Mr. Muzzafar Ahmed Mirza

DRAP has issued a rapid alert against falsified drug products, with spurious batches seized. PPMA supports this action to safeguard

With evolving US tariffs, Pakistan’s pharmaceutical industry is well-positioned to capture larger market share, reinforcing its reputation for quality and

𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 𝐚𝐧𝐝 𝐂𝐡𝐢𝐧𝐚 unite to build an advanced antibiotic plant driving innovation, boosting healthcare, and shaping a healthier tomorrow. As

Pakistan’s pharmaceutical industry is making waves internationally, fueled by its high-quality manufacturing and a significant rise in exports. 💊📈 With

Pakistan’s pharmaceutical industry has achieved a historic milestone, with pharmaceutical exports soaring by 34% in the fiscal year 2024-2025 (FY25)

Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets.

PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss

PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.

The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment